-
Hair cortisol and chronic stress exposure in chronic Hepatitis B patients
Hie-Won Hann, Jerrold Meyer, Grace Park, Peter D Block, Hee-Soon Juon
Research Article: Clinical Investigation
-
Hair cortisol and chronic stress exposure in chronic Hepatitis B patients
Hie-Won Hann, Jerrold Meyer, Grace Park, Peter D Block, Hee-Soon Juon
Research Article: Clinical Investigation
-
Hair cortisol and chronic stress exposure in chronic Hepatitis B patients
Hie-Won Hann, Jerrold Meyer, Grace Park, Peter D Block, Hee-Soon Juon
Research Article: Clinical Investigation
-
Hair cortisol and chronic stress exposure in chronic Hepatitis B patients
Hie-Won Hann, Jerrold Meyer, Grace Park, Peter D Block, Hee-Soon Juon
Research Article: Clinical Investigation
-
Hair cortisol and chronic stress exposure in chronic Hepatitis B patients
Hie-Won Hann, Jerrold Meyer, Grace Park, Peter D Block, Hee-Soon Juon
Research Article: Clinical Investigation
-
Hair cortisol and chronic stress exposure in chronic Hepatitis B patients
Hie-Won Hann, Jerrold Meyer, Grace Park, Peter D Block, Hee-Soon Juon
Research Article: Clinical Investigation
-
Hair cortisol and chronic stress exposure in chronic Hepatitis B patients
Hie-Won Hann, Jerrold Meyer, Grace Park, Peter D Block, Hee-Soon Juon
Research Article: Clinical Investigation
-
Hair cortisol and chronic stress exposure in chronic Hepatitis B patients
Hie-Won Hann, Jerrold Meyer, Grace Park, Peter D Block, Hee-Soon Juon
Research Article: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 6
Acknowledgements: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation